GSA Capital Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

GSA Capital Partners’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,559	Closed	-$1.27M	–	1895
2021 Q3	$1.27M	Buy	17,559 +251	+1%	+$19.2K	0.13%	195
2021 Q2	$1.66M	Buy	17,308 +14,250	+466%	+$1.57M	0.19%	96
2021 Q1	$452K	Sell	3,058 -3,011	-50%	-$546K	0.08%	409
2020 Q4	$849K	Buy	6,069 +1,240	+26%	+$201K	0.14%	179
2020 Q3	$733K	Buy	+4,829	New	+$788K	0.12%	210
2016 Q3	–	Sell	-132	Closed	-$144K	–	2020
2016 Q2	$144K	Buy	+132	New	+$166K	0.01%	1636

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Prelude Capital Management New York $1.3B AUM 62.01% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return